Thromboembolic events associated with angiogenesis inhibitors: a real-world study of data from the food and drug administration adverse event reporting system (FAERS) database
This study provides a real-world assessment of TEES risk associated with angiogenesis inhibitors. Identifying high-risk agents and temporal patterns underscores the need for early monitoring and highlights their contribution to TEEs in clinical practice.
Authors
- Peiguang Niu (ORCID: https://orcid.org/0000-0002-9262-9716)
- Meiling Wu (ORCID: https://orcid.org/0000-0002-1604-4572)
- Xiaoping Zeng (ORCID: https://orcid.org/0000-0002-9083-3860)
- Jintuo Zhou
- Huajiao Chen (ORCID: https://orcid.org/0009-0009-1622-933X)
- Tingting Chen (ORCID: https://orcid.org/0000-0001-8278-7131)
- Jinhua Zhang (ORCID: https://orcid.org/0000-0002-1178-2058)
- Ying Liu (ORCID: https://orcid.org/0000-0002-0543-0099)
- Yanting Zhu
Institutions
- Fujian University of Traditional Chinese Medicine (CN)
- Fujian Medical University (CN)
- Fuzhou Maternity and Child Health Care Hospital (CN)
Publication Details
- Journal
- Thrombosis Journal
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1186/s12959-025-00770-4
- Citations
- 3
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 4.16
Funders
- Fujian Medical University